A Multi-targeted Approach to Suppress Tumor-Promoting Inflammation

Cancers harbor significant genetic heterogeneity and patterns of relapse following many therapies are due to evolved resistance to treatment. While efforts have been made to combine targeted therapies, significant levels of toxicity have stymied efforts to effectively treat cancer with multi-drug co...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Semin Cancer Biol
Główni autorzy: Samadi, Abbas K., Georgakilas, Alexandros G., Amedei, Amedeo, Amin, Amr, Bishayee, Anupam, Lokeshwar, Bal L., Grue, Brendan, Panis, Carolina, Boosani, Chandra S., Poudyal, Deepak, Stafforini, Diana M., Bhakta, Dipita, Niccolai, Elena, Guha, Gunjan, Rupasinghe, H.P. Vasantha, Fujii, Hiromasa, Honoki, Kanya, Mehta, Kapil, Aquilano, Katia, Lowe, Leroy, Hofseth, Lorne J., Ricciardiello, Luigi, Ciriolo, Maria Rosa, Singh, Neetu, Whelan, Richard L., Chaturvedi, Rupesh, Ashraf, S. Salman, Kumara, HMC Shantha, Nowsheen, Somaira, Mohammed, Sulma I., Helferich, William G., Yang, Xujuan
Format: Artigo
Język:Inglês
Wydane: 2015
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635070/
https://ncbi.nlm.nih.gov/pubmed/25951989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2015.03.006
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy